Terns Pharmaceuticals Stock Forecast - 8 Period Moving Average
TERN Stock | USD 6.00 0.14 2.39% |
The 8 Period Moving Average forecasted value of Terns Pharmaceuticals on the next trading day is expected to be 6.03 with a mean absolute deviation of 0.41 and the sum of the absolute errors of 21.82. Terns Stock Forecast is based on your current time horizon. Investors can use this forecasting interface to forecast Terns Pharmaceuticals stock prices and determine the direction of Terns Pharmaceuticals's future trends based on various well-known forecasting models. We recommend always using this module together with an analysis of Terns Pharmaceuticals' historical fundamentals, such as revenue growth or operating cash flow patterns. Although Terns Pharmaceuticals' naive historical forecasting may sometimes provide an important future outlook for the firm, we recommend always cross-verifying it against solid analysis of Terns Pharmaceuticals' systematic risk associated with finding meaningful patterns of Terns Pharmaceuticals fundamentals over time.
Check out Historical Fundamental Analysis of Terns Pharmaceuticals to cross-verify your projections. Terns |
Most investors in Terns Pharmaceuticals cannot accurately predict what will happen the next trading day because, historically, stock markets tend to be unpredictable and even illogical. Modeling turbulent structures requires applying different statistical methods, techniques, and algorithms to find hidden data structures or patterns within the Terns Pharmaceuticals' time series price data and predict how it will affect future prices. One of these methodologies is forecasting, which interprets Terns Pharmaceuticals' price structures and extracts relationships that further increase the generated results' accuracy.
An 8-period moving average forecast model for Terns Pharmaceuticals is based on an artificially constructed time series of Terns Pharmaceuticals daily prices in which the value for a trading day is replaced by the mean of that value and the values for 8 of preceding and succeeding time periods. This model is best suited for price series data that changes over time. Terns Pharmaceuticals 8 Period Moving Average Price Forecast For the 28th of May
Given 90 days horizon, the 8 Period Moving Average forecasted value of Terns Pharmaceuticals on the next trading day is expected to be 6.03 with a mean absolute deviation of 0.41, mean absolute percentage error of 0.26, and the sum of the absolute errors of 21.82.Please note that although there have been many attempts to predict Terns Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Terns Pharmaceuticals' next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
Terns Pharmaceuticals Stock Forecast Pattern
Backtest Terns Pharmaceuticals | Terns Pharmaceuticals Price Prediction | Buy or Sell Advice |
Terns Pharmaceuticals Forecasted Value
In the context of forecasting Terns Pharmaceuticals' Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Terns Pharmaceuticals' downside and upside margins for the forecasting period are 1.13 and 10.92, respectively. We have considered Terns Pharmaceuticals' daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the 8 Period Moving Average forecasting method's relative quality and the estimations of the prediction error of Terns Pharmaceuticals stock data series using in forecasting. Note that when a statistical model is used to represent Terns Pharmaceuticals stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.AIC | Akaike Information Criteria | 102.0724 |
Bias | Arithmetic mean of the errors | 0.1357 |
MAD | Mean absolute deviation | 0.4117 |
MAPE | Mean absolute percentage error | 0.0729 |
SAE | Sum of the absolute errors | 21.8213 |
Predictive Modules for Terns Pharmaceuticals
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Terns Pharmaceuticals. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Terns Pharmaceuticals' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Other Forecasting Options for Terns Pharmaceuticals
For every potential investor in Terns, whether a beginner or expert, Terns Pharmaceuticals' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Terns Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Terns. Basic forecasting techniques help filter out the noise by identifying Terns Pharmaceuticals' price trends.Terns Pharmaceuticals Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Terns Pharmaceuticals stock to make a market-neutral strategy. Peer analysis of Terns Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Terns Pharmaceuticals by comparing valuation metrics with similar companies.
Risk & Return | Correlation |
Terns Pharmaceuticals Technical and Predictive Analytics
The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Terns Pharmaceuticals' price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Terns Pharmaceuticals' current price.Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Terns Pharmaceuticals Market Strength Events
Market strength indicators help investors to evaluate how Terns Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Terns Pharmaceuticals shares will generate the highest return on investment. By undertsting and applying Terns Pharmaceuticals stock market strength indicators, traders can identify Terns Pharmaceuticals entry and exit signals to maximize returns.
Terns Pharmaceuticals Risk Indicators
The analysis of Terns Pharmaceuticals' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Terns Pharmaceuticals' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting terns stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
Mean Deviation | 3.81 | |||
Standard Deviation | 4.96 | |||
Variance | 24.64 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Historical Fundamental Analysis of Terns Pharmaceuticals to cross-verify your projections. To learn how to invest in Terns Stock, please use our How to Invest in Terns Pharmaceuticals guide.You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.
Complementary Tools for Terns Stock analysis
When running Terns Pharmaceuticals' price analysis, check to measure Terns Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Terns Pharmaceuticals is operating at the current time. Most of Terns Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Terns Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Terns Pharmaceuticals' price. Additionally, you may evaluate how the addition of Terns Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas |
Is Terns Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Terns Pharmaceuticals. If investors know Terns will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Terns Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.26) | Revenue Per Share 0.035 | Return On Assets (0.24) | Return On Equity (0.35) |
The market value of Terns Pharmaceuticals is measured differently than its book value, which is the value of Terns that is recorded on the company's balance sheet. Investors also form their own opinion of Terns Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Terns Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Terns Pharmaceuticals' market value can be influenced by many factors that don't directly affect Terns Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Terns Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Terns Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Terns Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.